Cargando…

Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last Decade

Background: Starting from 2016, a major measles epidemic affected EU/EEA countries, after the measles incidence rate had progressively decreased from 2011 to 2015. Methods: This study describes measles incidences (ECDC reports), the vaccination coverages (VCs) (WHO/UNICEF reports) and the vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montalti, Marco, Kawalec, Anna, Leoni, Erica, Dallolio, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157557/ https://www.ncbi.nlm.nih.gov/pubmed/32075206 http://dx.doi.org/10.3390/vaccines8010086

Ejemplares similares

Perceptions of and Satisfaction with Sexual and Reproductive Health Interventions in Pre-Adolescent and Adolescent Students in UE/EEA Countries: A Systematic Review
por: Montalti, Marco, et al.
Publicado: (2023)

Comparison, by Country, of the Uptake of COVID-19 Vaccination by Health Care Workers in the EU/EEA
por: McGlacken, T, et al.
Publicado: (2023)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Immunisation Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016
por: Derrough, Tarik, et al.
Publicado: (2017)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
por: Ahmad, Amena A., et al.
Publicado: (2018)

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
por: Falla, Abby May, et al.
Publicado: (2018)

Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries
por: Lambert, Jan-Frederic, et al.
Publicado: (2021)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020
por: Van Heuverswyn, Jasper, et al.
Publicado: (2023)

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2022)

Rapid risk assessment from ECDC: Resurgence of reported cases of COVID-19 in the EU/EEA, the UK and EU candidate and potential candidate countries
Publicado: (2020)

Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017
por: Spiteri, G, et al.
Publicado: (2017)

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021
por: Angeloni, Giorgia, et al.
Publicado: (2023)

Screening for Infectious Diseases among Newly Arrived Migrants in EU/EEA Countries—Varying Practices but Consensus on the Utility of Screening
por: Kärki, Tommi, et al.
Publicado: (2014)

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review
por: Pottie, Kevin, et al.
Publicado: (2018)

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020
por: Högberg, Liselotte Diaz, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
por: Margineanu, Ioana, et al.
Publicado: (2022)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
por: Falla, A. M., et al.
Publicado: (2018)

Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review
por: Agbata, Eric N., et al.
Publicado: (2018)

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
por: Reusken, Chantal B.E.M., et al.
Publicado: (2020)

Healthcare workers’ knowledge, attitudes and behaviours with respect to antibiotics, antibiotic use and antibiotic resistance across 30 EU/EEA countries in 2019
por: Ashiru-Oredope, Diane, et al.
Publicado: (2021)

Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018
por: Benkő, Ria, et al.
Publicado: (2022)

Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review
por: Sandgren, Andreas, et al.
Publicado: (2014)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
por: Greenaway, Christina, et al.
Publicado: (2018)

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2020)

Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
por: Mollers, Madelief, et al.
Publicado: (2019)

Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis
por: Nakitanda, Aya Olivia, et al.
Publicado: (2021)

Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA
por: Suk, Jonathan E, et al.
Publicado: (2022)

Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
por: Seyler, T, et al.
Publicado: (2022)

Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study
por: Cravo Oliveira Hashiguchi, Tiago, et al.
Publicado: (2019)

Estimation of the number of exposed people during highly pathogenic avian influenza virus outbreaks in EU/EEA countries, October 2016–September 2018
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
por: Vanhamel, Jef, et al.
Publicado: (2023)

Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
por: Bivegete, Sandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1o3qgq9l52079pg3fdvu8p7nm5